National Bank of Canada
RLAY icon

National Bank of Canada’s Relay Therapeutics RLAY Stock Holding History

National Bank of Canada’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,600
Closed -$18.9K – 2890
2023
Q4 		$18.9K Hold
1,600
– – ﹤0.01% 2030
2023
Q3 		$12.9K Buy
+1,600
New +$17.2K ﹤0.01% 2139
2023
Q1 		– Sell
-750
Closed -$11.2K – 2834
2022
Q4 		$11.2K Buy
750
+250
+50% +$4.79K ﹤0.01% 2153
2022
Q3 		$0 Sell
500
-500
-50% -$11K ﹤0.01% 2856
2022
Q2 		$17K Buy
+1,000
New +$21.4K ﹤0.01% 2129

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

National Bank of Canada's RLAY Position: Q1 2024 in Review

National Bank of Canada sold out of Relay Therapeutics (RLAY) in Q1 2024, closing a stake of 1,600 shares — an estimated $18.9K sold.

National Bank of Canada first reported a position in RLAY in Q2 2022 and held it in 5 quarters. The position peaked at $18.9K in Q4 2023. 189 funds tracked by Wall St. Rank hold RLAY as of Q1 2024.

  • National Bank of Canada reported no remaining Relay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • National Bank of Canada sold 1,600 Relay Therapeutics shares in Q1 2024, an estimated $18.9K.
  • National Bank of Canada first reported a position in Relay Therapeutics in Q2 2022 and held it in 5 quarters.
  • National Bank of Canada's Relay Therapeutics position peaked at $18.9K in Q4 2023.
  • 189 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2024.

Based on National Bank of Canada's 13F filing for Q1 2024, filed 13 May 2024.